The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorUniversity of Mississippi Medical Center

About this trial

This research study wants to learn about Chronic Kidney Disease (CKD) with Obesity, and Heart Failure with preserved Ejection Fraction (HFpEF) and better ways to evaluate these diseases. HFpEF means that the heart is not able to fill properly with blood while it is resting so the amount of blood pumped out to the body is less than it would be if it was filling properly. The study is being done to describe the differences in how the kidneys handle protein and salt in participants with HFpEF and obesity compared to healthy persons.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults 18-75 years old

Normal kidney function

No heart failure

BMI 25-30kg/m2

Disqualifiers

Diagnosis of chronic illness

eGFR<60mL/min/1.73m2

Pregnancy or breast feeding

History of cutaneous or allergic reaction to iodine-based products of contrast dyes

Trial population

Community-dwelling ambulatory participants who have HFpEF and obesity. We will compare with health participants and participants with obesity but without HFpEF.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • High protein and sodium meal

    Other intervention

    Meal with 1g/kg protein content and 3900mg sodium

Treatment groups

60 Participants
are divided into 3 treatment groups
Group A: Healthy Participants1 intervention
Group B: Obese Participants without HFpEF1 intervention
Group C: HFpEF and Obese Participants1 intervention

Trial outcomes

Primary outcomes

1

Change in measured GFR

Time frame
5 hours
2

Change in urine sodium excretion

Time frame
5 hours

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.